title: Unmaintained cytogenetic and molecular remission in chronic myelogenous leukaemia following treatment by interferon.
authors.forename: B
authors.initials: B
authors.lastname: Rio
authors.forename: S
authors.initials: S
authors.lastname: Ramond
authors.forename: J M
authors.initials: JM
authors.lastname: Lacorte
authors.forename: D
authors.initials: D
authors.lastname: Pépin
authors.forename: V
authors.initials: V
authors.lastname: Barbu
authors.forename: F
authors.initials: F
authors.lastname: Viguie
authors.forename: F
authors.initials: F
authors.lastname: Ajchenbaum-Cymbalista
authors.forename: M
authors.initials: M
authors.lastname: Lorrot
authors.forename: J
authors.initials: J
authors.lastname: Chambaz
authors.forename: R
authors.initials: R
authors.lastname: Zittoun
mesh_terms: D000818:Animals; D002642:Chick Embryo; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D016898:Interferon-alpha